New research utilizing eye-tracking technology has demonstrated the ability to accurately distinguish between the roles of a ...
LYON, France--(BUSINESS WIRE)--Regulatory News: PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial ...
A new pilot study known as STAMINA (Senolytics To Alleviate Mobility Issues and Neurological Impairments in Aging), that focused on the effects of senolytic medications, Dasatinib and Quercetin (DQ), ...
First-of-its-Kind European Pilot Study Shows Improvement in Mood, Energy, and Anxiety—Fueling Hope for a New Mental Health Treatment SAN MATEO, Calif.--(BUSINESS WIRE)--Baszucki Group today announced ...